Stock chart
Ticker: RDUS Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
2022-08-12 2022-08-11 B Purchase

Rubric Capital Management LP

Large shareholder
1,678,954 +24.1%
10.07
16,907,067 USD
1,678,954 +24.1% 10.07 16,907,067 USD
2022-08-11 2022-08-10 B Purchase

Rubric Capital Management LP

Large shareholder
4,012 +0.1%
10.07
40,401 USD
4,012 +0.1% 10.07 40,401 USD
2022-05-20 2022-05-18 B Purchase

BIOTECH TARGET N V

Large shareholder
477,824 +5.8%
5.57
2,661,002 USD
477,824 +5.8% 5.57 2,661,002 USD
2022-01-07 2022-01-06 B Purchase

BIOTECH TARGET N V

Large shareholder
300,000 +3.8%
6.31
1,894,410 USD
300,000 +3.8% 6.31 1,894,410 USD
2022-01-07 2022-01-05 B Purchase

BIOTECH TARGET N V

Large shareholder
250,000 +3.2%
6.30
1,574,650 USD
250,000 +3.2% 6.30 1,574,650 USD
2021-12-16 2021-12-16 B Purchase

Rubric Capital Management LP

Large shareholder
146,685 +2.2%
7.07
1,037,752 USD
146,685 +2.2% 7.07 1,037,752 USD
2021-12-15 2021-12-15 B Purchase

Rubric Capital Management LP

Large shareholder
180,744 +2.7%
6.77
1,223,637 USD
180,744 +2.7% 6.77 1,223,637 USD
2021-12-15 2021-12-14 B Purchase

Rubric Capital Management LP

Large shareholder
94,103 +1.4%
6.81
640,936 USD
94,103 +1.4% 6.81 640,936 USD
2021-12-15 2021-12-13 B Purchase

Rubric Capital Management LP

Large shareholder
187,391 +3.0%
7.08
1,326,803 USD
187,391 +3.0% 7.08 1,326,803 USD
2021-12-10 2021-12-10 B Purchase

Rubric Capital Management LP

Large shareholder
768,171 +13.8%
7.18
5,511,627 USD
768,171 +13.8% 7.18 5,511,627 USD
2021-12-10 2021-12-09 B Purchase

Rubric Capital Management LP

Large shareholder
264,644 +5.0%
7.58
2,007,087 USD
264,644 +5.0% 7.58 2,007,087 USD
2021-12-10 2021-12-08 B Purchase

Rubric Capital Management LP

Large shareholder
560,691 +11.8%
8.02
4,497,078 USD
560,691 +11.8% 8.02 4,497,078 USD
2021-10-01 2021-09-29 B Purchase

BIOTECH TARGET N V

Large shareholder
100,000 +1.3%
12.95
1,294,500 USD
100,000 +1.3% 12.95 1,294,500 USD
2021-03-09 2021-03-05 PS Planned sale

Chopas James George

Principal Finance Accounting

Officer
370 -5.2%
20.88
7,726 USD
370 -5.2% 20.88 7,726 USD
2021-02-26 2021-02-25 S Sale

Grausso Sal

Chief Commercial Officer

Officer
1,322 -10.1%
18.93
25,025 USD
1,322 -10.1% 18.93 25,025 USD
2020-11-09 2020-11-05 B Purchase

BIOTECH TARGET N V

Large shareholder
100,000 +1.4%
14.26
1,426,230 USD
100,000 +1.4% 14.26 1,426,230 USD
2020-09-16 2020-09-14 B Purchase

BIOTECH TARGET N V

Large shareholder
200,000 +2.8%
11.69
2,338,680 USD
200,000 +2.8% 11.69 2,338,680 USD
2020-09-14 2020-09-11 B Purchase

BIOTECH TARGET N V

Large shareholder
199,029 +2.9%
11.33
2,255,118 USD
199,029 +2.9% 11.33 2,255,118 USD
2020-07-09 2020-07-08 B Purchase

BIOTECH TARGET N V

Large shareholder
25,000 +0.4%
13.21
330,178 USD
25,000 +0.4% 13.21 330,178 USD
2020-05-04 2020-04-30 B Purchase

BIOTECH TARGET N V

Large shareholder
50,000 +0.7%
15.75
787,555 USD
50,000 +0.7% 15.75 787,555 USD
2020-02-28 2020-02-26 PS Planned sale

Hughes Owen

Non-Executive Director
2,750 -20.5%
17.95
49,363 USD
2,750 -20.5% 17.95 49,363 USD
2020-02-28 2020-02-26 S Sale

Carmona Jose

Chief Financial Officer

Officer
1,292 -2.7%
17.93
23,169 USD
1,292 -2.7% 17.93 23,169 USD
2020-02-28 2020-02-26 PS Planned sale

Dere Willard H

Non-Executive Director
1,925 -13.6%
17.95
34,554 USD
1,925 -13.6% 17.95 34,554 USD
2020-02-28 2020-02-26 S Sale

Morris Charles Q

Chief Medical Officer

Officer
1,256 -3.6%
17.93
22,524 USD
1,256 -3.6% 17.93 22,524 USD
2020-02-28 2020-02-26 PS Planned sale

Rosenberg Anthony

Non-Executive Director
1,815 -12.8%
17.95
32,579 USD
1,815 -12.8% 17.95 32,579 USD
2020-02-28 2020-02-26 S Sale

Kelly Joseph Francis

Sr. VP of Sales and Marketing

Officer
889 -3.6%
17.93
15,942 USD
889 -3.6% 17.93 15,942 USD
2019-11-08 2019-11-06 B Purchase

BIOTECH GROWTH N V

Large shareholder
100,000 +1.5%
23.00
2,300,300 USD
100,000 +1.5% 23.00 2,300,300 USD
2019-07-03 2019-07-01 PS Planned sale

Rosenberg Anthony

1,584 -15.4%
24.60
38,966 USD
1,584 -15.4% 24.60 38,966 USD
2019-06-11 2019-06-07 B Purchase

Kelly Joseph Francis

Sr. VP of Sales and Marketing

2,500 +50.0%
21.81
54,536 USD
2,500 +50.0% 21.81 54,536 USD
2019-05-13 2019-05-10 B Purchase

Kelly Joseph Francis

Sr. VP of Sales and Marketing

2,000 +66.7%
21.43
42,860 USD
2,000 +66.7% 21.43 42,860 USD
2019-04-18 2019-04-16 PS Planned sale

Dere Willard H

1,680 -16.3%
22.22
37,330 USD
1,680 -16.3% 22.22 37,330 USD
2019-04-18 2019-04-16 PS Planned sale

Graves Kurt

4,800 -46.6%
22.32
107,136 USD
4,800 -46.6% 22.32 107,136 USD
2019-04-18 2019-04-16 PS Planned sale

Hughes Owen

2,400 -23.3%
22.22
53,328 USD
2,400 -23.3% 22.22 53,328 USD
2019-04-12 2019-04-11 PS Planned sale

Roychowdhury Debasish

4,800 -46.6%
22.15
106,320 USD
4,800 -46.6% 22.15 106,320 USD
2019-03-06 2019-03-05 B Purchase

Hopfield Jessica

12,800 +inf%
19.23
246,190 USD
12,800 +inf% 19.23 246,190 USD
2018-12-21 2018-12-20 B Purchase

BIOTECH GROWTH N V

Large shareholder
60,000 +0.9%
14.48
868,782 USD
60,000 +0.9% 14.48 868,782 USD
2018-12-18 2018-12-17 B Purchase

Kelly Joseph Francis

Sr. VP of Sales and Marketing

Officer
3,000 +inf%
15.71
47,130 USD
3,000 +inf% 15.71 47,130 USD
2018-12-17 2018-12-14 B Purchase

BIOTECH GROWTH N V

Large shareholder
60,000 +0.9%
15.64
938,256 USD
60,000 +0.9% 15.64 938,256 USD
2018-08-22 2018-08-20 B Purchase

BIOTECH GROWTH N V

Large shareholder
60,000 +0.9%
19.65
1,178,808 USD
60,000 +0.9% 19.65 1,178,808 USD
2018-08-16 2018-08-15 B Purchase

BIOTECH GROWTH N V

Large shareholder
69,363 +1.1%
20.78
1,441,530 USD
69,363 +1.1% 20.78 1,441,530 USD
2018-08-16 2018-08-14 B Purchase

BIOTECH GROWTH N V

Large shareholder
100,000 +1.6%
20.87
2,086,880 USD
100,000 +1.6% 20.87 2,086,880 USD
2018-08-10 2018-08-08 B Purchase

BIOTECH GROWTH N V

Large shareholder
60,000 +1.0%
22.73
1,363,884 USD
60,000 +1.0% 22.73 1,363,884 USD
2018-07-30 2018-07-27 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.8%
24.81
1,240,605 USD
50,000 +0.8% 24.81 1,240,605 USD
2018-07-26 2018-07-25 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.8%
27.28
1,363,805 USD
50,000 +0.8% 27.28 1,363,805 USD
2018-06-13 2018-06-11 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.8%
27.36
1,367,835 USD
50,000 +0.8% 27.36 1,367,835 USD
2018-05-24 2018-05-23 B Purchase

BIOTECH GROWTH N V

Large shareholder
40,000 +0.7%
28.91
1,156,320 USD
40,000 +0.7% 28.91 1,156,320 USD
2018-05-23 2018-05-21 B Purchase

BIOTECH GROWTH N V

Large shareholder
60,000 +1.0%
29.27
1,756,380 USD
60,000 +1.0% 29.27 1,756,380 USD
2018-04-23 2018-04-19 B Purchase

BIOTECH GROWTH N V

Large shareholder
40,000 +0.7%
33.80
1,351,936 USD
40,000 +0.7% 33.80 1,351,936 USD
2018-04-09 2018-04-05 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.9%
36.58
1,828,845 USD
50,000 +0.9% 36.58 1,828,845 USD
2018-03-06 2018-03-02 B Purchase

BIOTECH GROWTH N V

Large shareholder
80,000 +1.4%
32.52
2,601,448 USD
80,000 +1.4% 32.52 2,601,448 USD
2018-02-12 2018-02-09 B Purchase

BIOTECH GROWTH N V

Large shareholder
75,000 +1.3%
34.38
2,578,763 USD
75,000 +1.3% 34.38 2,578,763 USD
2017-11-16 2017-11-14 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.9%
26.25
1,312,390 USD
50,000 +0.9% 26.25 1,312,390 USD
2017-11-13 2017-11-10 B Purchase

Hatzis-Schoch Brent

Sr. VP, General Counsel

1,778 +355.6%
28.09
49,943 USD
1,778 +355.6% 28.09 49,943 USD
2017-11-07 2017-11-07 B Purchase

Hoiland Jesper

President and CEO

Executive Director
6,800 +111.5%
29.04
197,450 USD
6,800 +111.5% 29.04 197,450 USD
2017-11-07 2017-11-03 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.9%
29.15
1,457,575 USD
50,000 +0.9% 29.15 1,457,575 USD
2017-10-27 2017-10-26 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.9%
30.95
1,547,550 USD
50,000 +0.9% 30.95 1,547,550 USD
2017-10-26 2017-10-25 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.9%
32.85
1,642,415 USD
50,000 +0.9% 32.85 1,642,415 USD
2017-09-15 2017-09-15 B Purchase

Hoiland Jesper

President and CEO

Executive Director
6,100 +inf%
32.72
199,608 USD
6,100 +inf% 32.72 199,608 USD
2017-09-15 2017-09-14 B Purchase

Carmona Jose

Chief Financial Officer

3,000 +inf%
32.83
98,503 USD
3,000 +inf% 32.83 98,503 USD
2017-09-15 2017-09-14 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.9%
32.94
1,647,225 USD
50,000 +0.9% 32.94 1,647,225 USD
2017-09-15 2017-09-13 B Purchase

BIOTECH GROWTH N V

Large shareholder
100,000 +1.9%
33.71
3,370,750 USD
100,000 +1.9% 33.71 3,370,750 USD
2017-09-13 2017-09-12 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +0.9%
35.42
1,770,820 USD
50,000 +0.9% 35.42 1,770,820 USD
2017-09-07 2017-09-05 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +1.0%
36.75
1,837,625 USD
50,000 +1.0% 36.75 1,837,625 USD
2017-08-18 2017-08-16 B Purchase

BIOTECH GROWTH N V

Large shareholder
60,000 +1.2%
35.98
2,158,536 USD
60,000 +1.2% 35.98 2,158,536 USD
2017-08-11 2017-08-10 B Purchase

BIOTECH GROWTH N V

Large shareholder
75,000 +1.5%
34.26
2,569,500 USD
75,000 +1.5% 34.26 2,569,500 USD
2017-08-11 2017-08-09 B Purchase

BIOTECH GROWTH N V

Large shareholder
75,000 +1.5%
35.67
2,675,528 USD
75,000 +1.5% 35.67 2,675,528 USD
2017-05-31 2017-05-30 B Purchase

BIOTECH GROWTH N V

Large shareholder
40,000 +0.8%
34.21
1,368,348 USD
40,000 +0.8% 34.21 1,368,348 USD
2017-05-30 2017-05-25 B Purchase

BIOTECH GROWTH N V

Large shareholder
40,000 +0.8%
36.25
1,450,020 USD
40,000 +0.8% 36.25 1,450,020 USD
2017-05-22 2017-05-18 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +1.0%
34.41
1,720,345 USD
50,000 +1.0% 34.41 1,720,345 USD
2017-05-18 2017-05-17 B Purchase

BIOTECH GROWTH N V

Large shareholder
18,000 +0.4%
32.98
593,662 USD
18,000 +0.4% 32.98 593,662 USD
2017-05-18 2017-05-16 B Purchase

BIOTECH GROWTH N V

Large shareholder
17,000 +0.3%
33.93
576,725 USD
17,000 +0.3% 33.93 576,725 USD
2017-05-16 2017-05-12 B Purchase

BIOTECH GROWTH N V

Large shareholder
15,000 +0.3%
34.00
509,996 USD
15,000 +0.3% 34.00 509,996 USD
2017-05-11 2017-05-09 B Purchase

BIOTECH GROWTH N V

Large shareholder
50,000 +1.0%
35.93
1,796,480 USD
50,000 +1.0% 35.93 1,796,480 USD
2017-05-09 2017-05-08 B Purchase

BIOTECH GROWTH N V

Large shareholder
22,800 +0.5%
35.60
811,630 USD
22,800 +0.5% 35.60 811,630 USD
2017-05-09 2017-05-05 B Purchase

BIOTECH GROWTH N V

Large shareholder
20,600 +0.4%
35.55
732,283 USD
20,600 +0.4% 35.55 732,283 USD